Traded Apr 20 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Apr 17, 2026 · Filed Apr 22, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Traded Apr 20 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Eric Venker (President & Immunovant CEO) sold ~$5.92M of Roivant Sciences
Automatic saleTraded Apr 20 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.